Method for treating a perioheral arterial disease
US-2024425576-A1 · Dec 26, 2024 · US
against cytokines, lymphokines or interferons
against cytokines, lymphokines or interferons · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/24 |
| Official title | against cytokines, lymphokines or interferons |
| Display label | against cytokines, lymphokines or interferons |
| Total patents | 1,195 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 145 |
| 2016 | 116 |
| 2017 | 120 |
| 2018 | 120 |
| 2019 | 121 |
| 2020 | 112 |
| 2021 | 120 |
| 2022 | 90 |
| 2023 | 78 |
| 2024 | 90 |
| 2025 | 69 |
| 2026 | 14 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Differential diagnosis of eczema and psoriasis
US-12031182-B2 · Jul 9, 2024 · US
Humanization of rabbit antibodies using a universal antibody framework
US-11858981-B2 · Jan 2, 2024 · US
Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
US-9220244-B2 · Dec 29, 2015 · US
ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
US-9212227-B2 · Dec 15, 2015 · US
Antibodies against human TWEAK and uses thereof
US-9187564-B2 · Nov 17, 2015 · US
Treatment of chronic pelvic pain syndrome
US-9181577-B2 · Nov 10, 2015 · US
Low Affinity FCGR Deficient Mice
US-2015313195-A1 · Nov 5, 2015 · US
Activatable binding polypeptides and methods of identification and use thereof
US-9169321-B2 · Oct 27, 2015 · US
Reducer of immunosuppression by tumor cell and antitumor agent using the same
US-9169324-B2 · Oct 27, 2015 · US
Polynucleotides encoding IL-31 monoclonal antibodies
US-9156909-B2 · Oct 13, 2015 · US
Heterodimeric antibody Fc-containing proteins and methods for production thereof
US-9150663-B2 · Oct 6, 2015 · US
Novel epitope of ip-10 and antibody to same
US-2015266951-A1 · Sep 24, 2015 · US
Focused radiation for augmenting immune-based therapies against neoplasms
US-9132281-B2 · Sep 15, 2015 · US
Nucleic acids encoding neutralizing anti-CCL20 antibodies
US-9133273-B2 · Sep 15, 2015 · US
Material and methods for diagnosing and treating kawasaki disease and kls
US-2015247848-A1 · Sep 3, 2015 · US
Therapeutic DLL4 binding proteins
US-9115195-B2 · Aug 25, 2015 · US
Anti-jagged antibodies and methods of use
US-2015232568-A1 · Aug 20, 2015 · US
Material and methods for treating or preventing HER-3 associated diseases
US-9101760-B2 · Aug 11, 2015 · US
Perfusion media
US-2015210750-A1 · Jul 30, 2015 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/24?
- CPC C07K16/24 is the Cooperative Patent Classification code for “against cytokines, lymphokines or interferons.”
- How many patents are filed under CPC C07K16/24 (against cytokines, lymphokines or interferons)?
- Our database includes 1,195 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/24 growing?
- Publication counts under this code: 90 in 2024 vs 69 in 2025 (latest complete years).